MC1408A1 - Formule pharmaceutique topique antivirale a base de 9-(2-hydroxyethoxymethyl)guanine - Google Patents

Formule pharmaceutique topique antivirale a base de 9-(2-hydroxyethoxymethyl)guanine

Info

Publication number
MC1408A1
MC1408A1 MC811529A MC1529A MC1408A1 MC 1408 A1 MC1408 A1 MC 1408A1 MC 811529 A MC811529 A MC 811529A MC 1529 A MC1529 A MC 1529A MC 1408 A1 MC1408 A1 MC 1408A1
Authority
MC
Monaco
Prior art keywords
hydroxyethoxymethyl
guanine
formula based
antiviral pharmaceutical
pharmaceutical formula
Prior art date
Application number
MC811529A
Other languages
English (en)
French (fr)
Inventor
Trevor Mervyn Jones
Alan Robert White
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC1408(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1408A1 publication Critical patent/MC1408A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC811529A 1980-07-18 1981-07-17 Formule pharmaceutique topique antivirale a base de 9-(2-hydroxyethoxymethyl)guanine MC1408A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (1)

Publication Number Publication Date
MC1408A1 true MC1408A1 (fr) 1982-07-16

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811529A MC1408A1 (fr) 1980-07-18 1981-07-17 Formule pharmaceutique topique antivirale a base de 9-(2-hydroxyethoxymethyl)guanine

Country Status (30)

Country Link
EP (1) EP0044543B1 (en, 2012)
AR (1) AR225680A1 (en, 2012)
AT (1) AT381025B (en, 2012)
AU (1) AU547391B2 (en, 2012)
BG (1) BG60450B2 (en, 2012)
CA (1) CA1172169A (en, 2012)
CS (1) CS229674B2 (en, 2012)
CY (1) CY1309A (en, 2012)
DD (1) DD203464A5 (en, 2012)
DE (1) DE3163982D1 (en, 2012)
DK (1) DK149191C (en, 2012)
ES (1) ES504046A0 (en, 2012)
FI (1) FI76255C (en, 2012)
GB (1) GB2080106B (en, 2012)
GR (1) GR75104B (en, 2012)
HK (1) HK95485A (en, 2012)
HU (1) HU185936B (en, 2012)
IE (1) IE51120B1 (en, 2012)
IL (1) IL63351A (en, 2012)
IT (1) IT1171399B (en, 2012)
MC (1) MC1408A1 (en, 2012)
MY (1) MY8600389A (en, 2012)
NO (1) NO155038C (en, 2012)
NZ (1) NZ197744A (en, 2012)
PH (1) PH16308A (en, 2012)
PL (1) PL135416B1 (en, 2012)
PT (1) PT73391B (en, 2012)
RO (1) RO82678A (en, 2012)
SG (1) SG72085G (en, 2012)
ZW (1) ZW17181A1 (en, 2012)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
EP0561465B1 (en) * 1992-03-20 1997-09-17 Unichema Chemie B.V. Release composition
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
AU2036297A (en) * 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
RU2179851C1 (ru) * 2000-12-21 2002-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противовирусный фармацевтический состав
RU2175230C1 (ru) * 2001-01-23 2001-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция с противовирусной активностью и способ ее получения
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
CA2562190C (en) * 2004-04-05 2012-08-21 Laboratorios Liomont, S.A. De C.V. Novel antiviral pharmaceutical composition
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4144332A (en) * 1976-01-05 1979-03-13 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
PL135416B1 (en) 1985-10-31
IE811617L (en) 1982-01-18
DK149191B (da) 1986-03-10
GB2080106A (en) 1982-02-03
IL63351A (en) 1983-10-31
PH16308A (en) 1983-09-05
AR225680A1 (es) 1982-04-15
FI76255B (fi) 1988-06-30
RO82678A (ro) 1984-05-23
CY1309A (en) 1985-12-06
NO155038B (no) 1986-10-27
AT381025B (de) 1986-08-11
DK149191C (da) 1986-09-08
IT8148925A0 (it) 1981-07-17
DD203464A5 (de) 1983-10-26
IE51120B1 (en) 1986-10-01
HK95485A (en) 1985-12-06
DE3163982D1 (en) 1984-07-12
FI76255C (fi) 1990-03-14
IT1171399B (it) 1987-06-10
ES8305363A1 (es) 1983-04-01
NO155038C (no) 1987-02-04
PT73391B (en) 1983-06-15
GB2080106B (en) 1984-03-07
EP0044543B1 (en) 1984-06-06
NO812464L (no) 1982-01-19
BG60450B2 (bg) 1995-04-28
EP0044543A1 (en) 1982-01-27
ATA318081A (de) 1986-01-15
IL63351A0 (en) 1981-10-30
HU185936B (en) 1985-04-28
NZ197744A (en) 1983-05-10
ES504046A0 (es) 1983-04-01
GR75104B (en, 2012) 1984-07-13
AU547391B2 (en) 1985-10-17
DK321681A (da) 1982-01-19
MY8600389A (en) 1986-12-31
PL232259A1 (en) 1983-07-04
CS229674B2 (en) 1984-06-18
FI812257L (fi) 1982-01-19
AU7307381A (en) 1982-01-21
PT73391A (en) 1981-08-01
SG72085G (en) 1986-05-02
ZW17181A1 (en) 1983-02-23
CA1172169A (en) 1984-08-07

Similar Documents

Publication Publication Date Title
MC1408A1 (fr) Formule pharmaceutique topique antivirale a base de 9-(2-hydroxyethoxymethyl)guanine
US4355032B2 (en) 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
DE3485225D1 (de) Antivirale guanin-derivate.
CY2008001I1 (el) Antiviral compounds
DE3671227D1 (de) 9-substituierte guaninmonohydrate.
IT1206954B (it) Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
DK143390C (da) Hjulunderstel
NO882926D0 (no) Antivirale preparater inneholdende cyklodextriner.
IT1212512B (it) Preparato farmaceutico a base di potassio a cessione controllata
AU1527983A (en) Topical pharmaceutical compositions containing 9- (2-hydroxyethoxymethyl) guanine
BR8000103A (pt) Bomba a pistoes radiais
DE3675846D1 (de) Guaninderivate.
IT7847623A0 (it) Medicamento a base d'un composto eterociclico biciclico condensato
FI780626A7 (fi) Foerfarande foer framstaellning av 9-(2-hydroximetyl) guaninmonofosfat
DK541078A (da) 8-og/eller 9-substituerede 2-benzazepinforbindelser
IT7926663A0 (it) Composizione farmaceutica anti-influenzale a base di combinazioni antivirali.
LV5704A3 (lv) 9-(2-Oksietoksimetil)guanina iegusanas panemiens
SU650650A2 (ru) Элеваторное колесо
KE3561A (en) Topical formulations of 9-(2-hydroxyethoxymethyl)guanine
ZA833947B (en) Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl)guanine
NO160260C (no) 9-(1,3-dihydroksy-2-propoksymetyl)-guanin-derivater.
ATA282287A (de) Antivirale 8-phenylxanthine
SE8205959D0 (sv) Novel derivatives of guanine
FI900420A7 (fi) Menetelmä 9-(2-hydroksietoksimetyyli)guaniinin valmistamiseksi
PH20944A (en) Antiviral guanine derivatives

Legal Events

Date Code Title Description
YP Annual fee paid